FDA
| Tracking # |
2023-4208 FDA23092658 |
| Submitted | May 17, 2023 |
MuckRock users can file, duplicate, track, and share public records requests like this one. Learn more.
Communications
From: Samantha Liss
To Whom It May Concern:
Pursuant to the Freedom of Information Act, I hereby request the following records:
Agenda, meeting minutes, presentations, handouts, transcript, a list of participants from the June 2, 2021 meeting between the American Society of Health-System Pharmacists (ASHP) and Peter Marks of the FDA.
The requested documents will be made available to the general public, and this request is not being made for commercial purposes.
In the event that there are fees, I would be grateful if you would inform me of the total charges in advance of fulfilling my request. I would prefer the request filled electronically, by e-mail attachment if available or CD-ROM if not.
Thank you in advance for your anticipated cooperation in this matter. I look forward to receiving your response to this request within 20 business days, as the statute requires.
Sincerely,
Samantha Liss
From: Food and Drug Administration
*** This is an automated message. Please do not reply to this email. ***
Reference: FDA23092658
Dear Requester,
This is to confirm that you submitted a request for record(s) from the Food and Drug Administration
pursuant to the Freedom of Information Act.
FOIA staff will review your request to determine whether it has sufficient information to be processed;
if so, you will receive another email as a formal acknowledgement of your request, with a control number for your request.
If your request is not sufficiently described,
or if there are any other deficiencies with your submission, FOIA staff will contact you via telephone or email.
From: Food and Drug Administration
Control number: 2023-4208
Please find the attached acknowledgement regarding your FOIA request. Note: Do NOT reply directly to this E-mail
From: Samantha Liss
Hello,
I wanted to follow up about my FOIA request regarding control number: 2023-4208.
From: Food and Drug Administration
Your request is pending with our Center for Biologics. That office has a significant FOIA backlog due to requests and litigation involving COVID-19 vaccines.
Sarah B. Kotler, J.D.
Director, Division of Freedom of Information
US FDA
301-796-8976
From: Food and Drug Administration
Good morning,
The system shows your request has been assigned to the Center for Biologics Evaluation and Research (CBER) FOIA office for processing. I’ve requested they provide you with a status update.
Sincerely,
C.
___________________________
Ms. Charis Wilson, PhD, CRM
Denials & Appeals Officer
Freedom of Information Division
FDA Office of the Commissioner
“What we find changes who we become.” – Peter Morville
From: Food and Drug Administration
Dear Ms. Liss,
Please see attached for the response to your Freedom of Information Act (FOIA) request # 2023-4208. When possible, please reply to this e-mail to confirm receipt of your FOIA response.
Sincerely,
Elizabeth Sly, M.S.
Science Disclosure Analyst
Phone: 240.402.8001
Email: Elizabeth.Sly@fda.hhs.gov<mailto:Elizabeth.Sly@fda.hhs.gov>
Access Litigation and Freedom of Information Branch (ALFOIB)
Division of Disclosure and Oversight Management (DDOM)
Office of Communication Outreach and Development (OCOD)
Center for Biologics Evaluation and Research (CBER)
U.S. Food and Drug Administration (FDA)
Files
pages